| Intrinsic resistance to tyrosine kinase inhibitors is associated with poor ... - UroToday |
|
|
UroToday Data on sequential therapy in patients with metastatic renal cell carcinoma (mRCC) and intrinsic resistance to receptor tyrosine kinase inhibitor (rTKI) treatment remains vague. We retrospectively studied treatment characteristics and outcome of mRCC |